Health & Biotech
Check out the latest Health news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
PharmAust bolsters manufacturing leadership to expand path to commercialisation
Health & Biotech
Neurotech reports positive top-line Phase 1/2 Rett Syndrome clinical trial results
News
Top 10 at 11: A ‘non-therapeutic’ med launch hits big, DUB hits the skids
Health & Biotech
PharmAust inks approval from Macquarie University for Open-Label MND extension study
Health & Biotech
Neurotech hits new milestone in Phase II/III autism trial after treating last patient
Stockhead TV
WTF with Race Oncology: Changing the chemo game
Health & Biotech
AdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapy
Health & Biotech
Online sales of Calmer Co wellness products surpasses 10k per day for March
Health & Biotech
Medtech Optiscan beefs up operations in US, hires two high-level execs
Health & Biotech
MGC Pharmaceuticals rebrands as Argent BioPharma in strategic transformation
News
ASX Small Caps and IPO Weekly Wrap: Goldies ruled the roost as we got teased by a 10-bagger
News
ASX Small Caps Lunch Wrap: Osteopore’s gone 1000% bananas, and here’s the rest of the news.
Health & Biotech
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024
News
Top 10 at 11: Big tick for Aussie health tech in Asia, and some solid silver and graphite news
Health & Biotech
Race Oncology achieves ‘major milestone’ in progress of lead drug to human trials
Health & Biotech
Up and away – EZZ partners with Asia Pacific Aviator Club
Health & Biotech
US medtech executive to join Aroa Biosurgery board
Health & Biotech
LTR Pharma commences dosing for pivotal erectile dysfunction study of SPONTAN
Health & Biotech
PharmAust files groundbreaking MND/ALS clinical data with the FDA
Health & Biotech
International cardiometabolic expert to join Race Oncology’s scientific advisory board
Health & Biotech
EZZ products to gain exposure to increasing Chinese tourist numbers at Auckland airport under duty-free deal
Health & Biotech
Neurotech extends clinical trials for the $US2bn Rett Syndrome market
Health & Biotech
Dimerix completes ‘highly strategic’ $20m cap raise to advance ACTION3 Phase 3 trial
Health & Biotech
‘A key milestone’: Dimerix ACTION3 Phase 3 trial interim results meet endpoint
Health & Biotech
ASX Health Stocks: Dimerix ACTION3 Phase 3 interim trial results are out… and they’re good
Health & Biotech
AdAlta’s Ad-214 extension study reaches milestone for Phase II clinical studies and partnering
Health & Biotech
Nova Eye Medical hits new US sales record following improved uptake of iTrack Advance products
Tech
SafeWatch to call time on workplace mental health crisis
Health & Biotech
PharmAust’s MPL could offer MND/ALS patients up to 56.5 months additional life expectancy
Health & Biotech
Interim results for Dimerix’s Phase 3 trial of DXB-200 for FSGS kidney disease on track for release in March 2024
Stockhead TV
What’s in store for 2024: Paradigm Biopharmaceuticals
Health & Biotech
Regal cornerstones $14m CardieX raise as medtech prepares to debut world-first vascular biometric monitor
Health & Biotech
PharmAust forms scientific advisory board to guide next phase of monepantel for treatment of MND/ALS
Health & Biotech
Neurotech reports sustained clinical progress in PANDAS/PANS patients during Phase I/II extension study
Health & Biotech
LTR Pharma firms up study for erectile dysfunction with patient recruitment
Health & Biotech
FDA shows the way for accelerated approval of PharmAust’s monepantel in MND
Stockhead TV
Long Shortz with AROA Biosurgery: A chance at a smoother recovery from a Mastectomy? Thanks Enivo
Health & Biotech
PharmAust extension study begins as analysis shows MND/ALS drug ‘defied the odds’
Health & Biotech
Countdown on to AdAlta trial results as biotech advances partner discussions
Health & Biotech
EZZ expands range with launch of three new health and wellness products
Health & Biotech
‘Monumental’– Bioxyne subsidiary awarded Australia’s first GMP licence to manufacture psilocybin and MDMA
Health & Biotech
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Stockhead TV
What’s in Store for 2024: Race Oncology
News
Morgan Stanley name drops ASX-listed Ebos as likely to fatten-up on Asia’s Ozempic weight-loss craze
Experts
MoneyTalks: Why this portfolio manager is bullish on the most shorted lithium stock on the ASX
Health & Biotech
PharmAust gets ethics committee green light for open-label MND extension study
Health & Biotech
Neurotech gets green light to start phase I/II cerebral palsy trial
Load More